Supernus Pharmaceuticals Inc. (SUPN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Supernus Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$41.08
+0.29% today
Market cap
$2.4B
Overall quality
—
Kronos AI 30-day
+8.3%
8 of 8 simulated paths end higher
Supernus Pharmaceuticals Inc. (SUPN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.4B. It trades at $41.08, up 0.29% today. 2 analysts' average target of $60.00 implies +46.1% from today's price. Kronos AI's 30-day forecast is +8.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $60.00 |
| Low – high | $55.00 – $65.00 |
| Analysts | 2 |
| Upside to average | +46.1% |
Kronos AI 30-day forecast
| Expected close | $44.35 (+8.3%) |
| Likely range | +5.8% … +17.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.